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Particulate air pollution has been linked to
increased mortality and morbidity. Several
reviews summarizing and evaluating health
effects of particulate air pollution have been
published (ATS 1996; Pope 2000; Pope et al.
1995). Adverse effects of air pollution include
an increase in cardiovascular and respiratory
deaths among elderly people as well as
increased hospital admissions for heart and
respiratory diseases (Borja-Aburto et al. 1998;
Burnett et al. 1999; Dab et al. 1996; Delﬁno
et al. 1994; Prescott et al. 1998; Schwartz
1994, 1999; Sheppard et al. 1999; Spix and
Wichmann 1996; Thurston 1996; Zanobetti
et al. 2000; Zmirou et al. 1998). With the
improvement of measurement techniques,
clearer effects were observed with smaller parti-
cle size fractions. In studies where both PM10
(particulate matter < 10 µm in diameter) and
PM2.5 (particulate matter < 2.5 µm in diame-
ter) data were available to characterize the
ambient concentrations of particle mass, there
were indications that PM2.5 was more strongly
associated with mortality than was PM10
(Dockery et al. 1992; Schwartz et al. 1996).
Recent studies on subjects with respiratory
diseases showed effects of ultrafine particles
(UFP) on peak expiratory flow, symptoms,
and medication use (Klot et al. 2002;
Pekkanen et al. 1997; Peters et al. 1997b).
A study on daily mortality from Erfurt,
Germany, found comparable effects of fine
particles and UFP in all size classes consid-
ered. However, effects of fine particles were
more immediate, whereas UFP showed rather
delayed effects on mortality (Wichmann
et al. 2000).
There is only a moderate body of evidence
from epidemiologic studies on effects of parti-
cles on the cardiovascular system. Although
mortality studies and hospital admission data
show the largest effects among people with
cardiovascular and respiratory diseases, most
of the evidence on cardiovascular effects was
derived from studies in healthy subjects.
Recently published literature suggests that
potential mechanisms of particulate matter
toxicity affecting cardiovascular health include
the alteration of the autonomic nervous system
(Dockery 2001), systemic and local inﬂamma-
tory events (Liao et al. 1999; Seaton et al.
1995), and alterations in blood coagulability
(Peters et al. 2000b; Pekkanen et al. 2000).
Studies on the daily variation of particu-
late air pollution and heart rate variability, a
marker of autonomic function of the heart, in
elderly subjects showed a decrease in heart
rate variability associated with particulate air
pollution (Creason et al. 2001; Gold et al.
2000; Liao et al. 1999; Pope et al. 1999a).
Further, results of a study by Pope et al.
(1999b) indicated an increase in pulse rate in
association with PM10, and an increase in
heart rate was observed during an air pollu-
tion episode in Germany (Peters et al. 1999).
Blood pressure and heart rate are physiologic
parameters that can be used to assess changes
in the autonomic control of the heart and
vascular tone (Grassi et al. 1998; Noll et al.
1998). Elevated blood pressure is a well-
established risk factor for cardiovascular mor-
bidity and mortality (Welin et al. 1993).
Recent analyses of air pollution effects on
blood pressure in a population-based sample
as well as in a panel of asthmatic subjects
found an increase in systolic blood pressure
with elevated concentrations of particulates
(Ibald-Mulli et al. 2001; Linn et al. 1999).
Given previous study results, the purpose of
this analysis was to assess whether ﬁne parti-
cles and UFP in ambient air are associated
with elevated blood pressure as well as heart
rate in subjects with preexisting heart disease.
The analyses have been conducted as part of
ULTRA, the European multicenter study on
exposure and risk assessment for ﬁne particles
and UFP in ambient air.
Materials and Methods
Study population. The ULTRA study was a
multicenter study with centers in Amsterdam
(the Netherlands), Erfurt (Germany), and
Helsinki (Finland). In each center, a panel of
subjects with coronary heart disease was stud-
ied for 6 months during the winter of
1998–1999. The study protocol consisted of
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Given the hypothesis that air pollution is associated with elevated blood pressure and heart rate,
the effect of daily concentrations of air pollution on blood pressure and heart rate was assessed in
131 adults with coronary heart disease in Helsinki, Finland; Erfurt, Germany; and Amsterdam,
the Netherlands. Blood pressure was measured by a digital monitor, and heart rate was calculated
as beats per minute from an electrocardiogram recording with the patient in supine position.
Particle concentrations were measured at central measuring sites. Linear regression was used to
model the association between 24-hr mean concentrations of particles and blood pressure and
heart rate. Estimates were adjusted for trend, day of week, temperature, barometric pressure, rela-
tive humidity, and medication use. Pooled effect estimates showed a small signiﬁcant decrease in
diastolic and systolic blood pressure in association with particulate air pollution; a slight decrease
in heart rate was found. Of the three centers, Erfurt revealed the most consistent particle effects.
The results do not support findings from previous studies that had shown an increase in blood
pressure and heart rate in healthy individuals in association with particles. However, particle
effects might differ in cardiac patients because of medication intake and disease status, both affect-
ing the autonomic control of the heart. Key words: autonomic control, blood pressure, cardiovas-
cular disease, ﬁne and ultraﬁne particles, heart rate. Environ Health Perspect 112:369–377 (2004).
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Environmental Medicine Articleclinical visits once every 2 weeks and daily
recording of symptoms and medication use.
Subjects who were included in the study had
to be free-dwelling nonsmokers and ≥ 50 years
of age with doctor-diagnosed coronary heart
disease. Subjects with a recent (< 3 months)
cardiac event such as myocardial infarction,
stroke, coronary artery bypass graft, or percu-
taneous transluminal coronary angioplasty
(PTCA) were excluded from the panels. Other
exclusion criteria were unstable angina pectoris
and type 1 diabetes mellitus. Subjects were
examined by a physician to exclude persons
who were too ill, unable to perform the exer-
cise challenge, or likely to have problems with
the study for other reasons. The subjects were
characterized by a questionnaire and a record-
ing of a 12-lead standard resting electro-
cardiogram (ECG).
In Amsterdam, panelists were recruited by
sending out information letters and screening
questionnaires to retirement homes. Because
the response was low, a newspaper advertise-
ment was used and letters were distributed in
areas mainly inhabited by senior citizens to
enroll more subjects. Finally, subjects were
recruited via the department of cardiology of
the academic medical center. In Erfurt, the
study population was recruited through a
local cardiologist. In Helsinki, subjects were
recruited by an advertisement in the journal
of a patient organization of the Finnish Heart
Association. Furthermore, information letters
were distributed to members of the associa-
tion with the postal code of the study area of
Helsinki and to physical rehabilitation
groups of the association. In addition, sub-
jects were recruited by an advertisement in a
local newspaper.
From each subject, a written consent was
obtained. In each study center the study pro-
tocol was approved by the responsible review
board.
Blood pressure and heart rate measure-
ments. All methods used in the ULTRA study
were conducted according to standard oper-
ating procedures (SOPs) developed for the
ULTRA study (Pekkanen and Timonen
2000). The clinical visit included the recording
of a ﬁve-lead ECG during a standardized pro-
tocol, which consisted of 5-min periods of rest
in supine position, rest in supine position with
paced breathing, and standing in upright posi-
tion. Further, a 6-min light exercise challenge
with a bicycle ergometer and a 10-min rest in
supine position were included. For each sub-
ject, the visit was always scheduled for the same
weekday and at the same time of the day. The
daily medication of the subjects was recorded
and not changed for the clinical visit. The
ambulatory ECG was recorded with an Oxford
MR-63 tape recorder (Oxford Instruments,
Abington, UK). Two-channel recordings were
performed with standard electrode position
recommended by the manufacturer. The ECG
recordings were analyzed with the Oxford Exel
Medilog II V 7.5 system (Oxford Instruments)
at Kuopio University Hospital. Trained
research assistants reviewed and, when neces-
sary, interactively edited the automatically pre-
determined beat-to-beat intervals. During the
ECG recording, blood pressure was measured
with a digitalized monitor (Omron M4;
OMRON Medizintechnik Handelsgesellschaft
GmbH, Mannheim, Germany) according to
the instruction manual. Blood pressure was
measured twice in supine position with 45 sec
between measurements. For the analyses, sys-
tolic and diastolic blood pressure in supine
position was calculated as the mean from the
two measurements in supine position. After
postural change from supine to standing posi-
tion, blood pressure was measured again after 3
min of standing. Heart rate was calculated as
beats per minute from the total number of cor-
rected normal-to-normal beat intervals during
the 5 min of rest in supine position.
Air pollution monitoring. In each city,
concentrations of ambient air pollutants were
measured at a fixed monitoring site repre-
senting urban background levels according to
the ULTRA SOPs (Pekkanen and Timonen
2000). Size distributions of particle number
concentrations were measured with aerosol
spectrometers, which had been compared
thoroughly in previous side-by-side ambient
air measurements (Khlystov et al. 2001;
Mirme et al. 2002; Tuch et al. 2000).
Fractions of number concentrations in dif-
ferent size classes were determined to form
one size class for UFP, (particles in the size
range of 0.01–0.1 µm) and one for accumu-
lation mode particles (ACP), (particles in
the size range of 0.1–1.0 µm). PM2.5 was
measured with Harvard impactors (Air
Diagnostics and Engineering Inc., Harrison,
ME, USA).
Data on meteorologic variables as well as
PM10, oxides of nitrogen, carbon monoxide,
sulfur dioxide, and ozone were collected from
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Table 1. Description of the study population and heart rate and blood pressure variables during resting in
supine position.
Differencea
Amsterdam Erfurt Helsinki between centers
No. of subjects 37 47 47
No. of clinical visits 429 491 511
No. of ECG recordings 413 472 509
No. of heart rate measurements 366 417 460
No. of blood pressure readings 414 471 495
Sex [n (%)]
Female 13 (35) 4 (9) 23 (45) 1
Male 24 (65) 43 (9) 24 (55)
Age [years, mean (range)] 71.5 (54–84) 64.6 (40–78) 68.3 (54–83) 2
Body mass index [mean (range)] 27.4 (19–34) 27.2 (22–33) 28.8 (20–36) NS
Medical history [n (%)]
Myocardial infarction 26 (70) 33 (30) 27 (57) NS
Coronary bypass or PTCA 17 (46) 34 (72) 23 (49) 1
Hypertension 18 (49) 31 (66) 29 (62) NS
Type 2 diabetes mellitus 2 (5) 8 (7) 5 (11) NS
Smoking [n (%)]
Never-smoker 7 (19) 10 (21) 21 (45) 1
Ex-smoker 30 (81) 37 (79) 26 (55)
Environmental tobacco smoke 4 (11) 8 (17) 0 (0) 1
at home [n (%)]
Daily medication use [n (%)]
Beta-blockers 13 (35) 35 (74) 31 (66) 1
ACE inhibitors or AT2 blockers 12 (32) 25 (53) 10 (21) 1
Ca2+ blockers 11 (30) 18 (38) 13 (28) NS
Diuretics 6 (16) 20 (43) 13 (28) 1
Combined blood medicationb 9 (24) 28 (58) 13 (28) 1
Digitalis 2 (5) 9 (19) 7 (15) 1
Nitrates 7 (19) 17 (36) 19 (40) 1
Any cardiac medication 27 (73) 45 (96) 45 (96) 1
Heart rate (beats/min) 62 ± 11 66 ± 11 60 ± 8 2
Systolic blood pressure in supine 140 ± 19 133 ± 18 142 ± 22 2
position (mm/Hg; mean ± SD)
Diastolic blood pressure in supine 84 ± 11 80 ± 8 77 ± 12 3
position (mm/Hg; mean ± SD)
Systolic blood pressure in standing 144 ± 22 138 ± 20 150 ± 26 2
position (mm/Hg; mean ± SD)
Diastolic blood pressure in standing 86 ± 12 84 ± 10 87 ± 11 NS
position (mm/Hg; mean ± SD)
NS, nonsigniﬁcant.
a1 = chi squared test, p < 0.05; 2 = difference between Erfurt and Amsterdam and between Erfurt and Helsinki, Tukey’s
test, p < 0.05; 3 = All centers different, Tukey’s test, p < 0.05. bAny combination of beta-blockers, ACE inhibitors, Ca2+
blockers, and diuretics.existing networks. All variables are 24-hr
means from 1200 hr to 1200 hr.
Data analysis. Data were analyzed using
the statistical package SAS (version 8; SAS
Institute Inc., Cary, NC, USA) and S-Plus
2000 (professional release 1; Insightful Corp.,
Seattle, WA, USA). Blood pressure and heart
rate measurements were checked for autocor-
relation within each subject for the repeated
measurements. Because of different climatic
and topographic conditions of each location,
basic model building was done for each panel
separately. Nonparametric smooth functions
based on locally weighted least squares in 
S-Plus were applied to explore the shape of
the association between confounders and the
dependent variable. The following covariates
were considered: an indicator variable for
each subject, long-term time trend, tempera-
ture (lags 0–3), relative humidity (lags 0–3),
barometric pressure (lags 0–3), blood pressure
active medication, and day of the week of the
visit. Criteria for building the basic model
were Akaike’s Information Criterion and
exposure–response plots. Because there was
no autocorrelation for within-subject meas-
urements, no adjustment for autocorrelation
was necessary. In general, the model with the
lowest Akaike’s Information Criterion was
selected (Pekkanen and Timonen 2000).
For the blood pressure analyses, the basic
model for the Amsterdam panel included a
smooth function for time trend, a quadratic
term for temperature, a smooth function for
relative humidity, and a linear term for baromet-
ric pressure. The basic model for Erfurt included
a quadratic term for time trend and smooth
functions for temperature, relative humidity,
and barometric pressure. The basic model for
Helsinki included a quadratic term for time
trend, smooth functions for temperature and
barometric pressure, and a linear term for rela-
tive humidity. Use of any blood pressure active
medication was included as categorical variable
in all three models to control for individual
medication intake. Further, day of the week was
included as categorical variable to adjust for a
potential cluster effect because of examining the
same groups of subjects on the same days of the
week. The confounder models for heart rate
were as follows: for Amsterdam, linear terms for
time trend, temperature, relative humidity, and
barometric pressure; for Erfurt, a smooth func-
tion for time trend and barometric pressure and
quadratic terms for temperature and relative
humidity; for Helsinki, smooth functions for
time trend, temperature, and barometric pres-
sure and a linear term for relative humidity.
Based on the model selection criteria, day of the
week and medication intake were added to all
three models as categorical variables. Subgroup
analyses were conducted by disease status.
For the calculation of the effect estimates
in S-Plus, the default setting of the conver-
gence criteria was reset to ε = 10 × 10–15, and
the maximum iterations was increased to 1,000
to avoid iterations being prematurely halted at
something other than the maximum likelihood
solution. In addition to the S-Plus models with
nonparametric confounder adjustment, effects
were also estimated using the mixed procedure
in SAS with parametric terms to adjust for
trend, temperature, barometric pressure, and
relative humidity. The effects were more con-
servative using S-Plus software compared with
SAS. Therefore, the results based on the non-
parametric adjustment for confounders using
S-Plus are presented.
Pooled effect estimates were calculated
as a weighted average of the center-specific
estimates using the inverse of the center-
speciﬁc variances as weights. The heterogeneity
between centers was tested with chi-squared
test. For heterogeneous estimates, random
effect models were applied to calculate pooled
effects (Spix et al. 1998).
Results
Descriptive characteristics of the study popula-
tions and the physiologic variables blood pres-
sure and heart rate during the resting period in
supine position are given in Table 1. Overall,
there were 131 subjects and 1,431 clinical vis-
its. Subjects in the Erfurt panel were younger,
their blood pressure was lower, and their
heart rate was higher than those of subjects
from the Amsterdam and Helsinki panels.
History of coronary bypass or PTCA and use
of blood pressure medication such as beta-
blockers, angiotensin-converting enzyme
(ACE) inhibitors, and diuretics differed sig-
niﬁcantly between centers. Subjects in Erfurt
took significantly more combinations of
blood pressure active medication than did
participants in the other two centers. Overall,
cardiac medication intake was > 70% in all
three centers.
The study period in Amsterdam was from
3 November 1998 until 18 June 1999, in
Erfurt from 14 October 1998 until 31 March
1999, and in Helsinki from 2 November until
30 April 1999. Particulate and gaseous air pol-
lutants and meteorologic variables are given in
Table 2. Mean and maximum number concen-
trations of UFP (0.01–0.1 µm) were highest in
Erfurt; Amsterdam and Helsinki had similar
concentrations of UFP. The mean number
concentration of ACP (0.1–1.0 µm) was
Environmental Medicine | Particle effects on blood pressure and heart rate
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Table 2. Summary statistics of daily concentrations of air pollutants, temperature, relative humidity, and
barometric pressure during the study period.a
No. Mean Minimum 25thb 50thb 75thb Maximum
UFP (n/cm3)
Amsterdam 216 17,338 5,699 12,614 17,147 21,322 37,195
Erfurt 177 21,124 3,867 12,401 19,198 27,933 96,678
Helsinki 182 17,041 2,305 11,052 14,886 20,879 50,306
ACP (n/cm3)
Amsterdam 202 2,131 413 1,212 1,874 2,795 6,413
Erfurt 177 1,829 303 964 1,492 2,237 6,848
Helsinki 176 1,390 344 909 1,200 1,672 3,782
PM2.5 (µg/m3)
Amsterdam 228 20.0 3.8 10.4 16.9 23.9 82.2
Erfurt 161 23.1 4.5 10.5 16.3 27.4 118.1
Helsinki 181 12.7 3.1 8.1 10.6 16.0 39.8
CO (mg/m3)
Amsterdam 237 0.6 0.4 0.5 0.6 0.7 1.6
Erfurt 176 0.4 0.1 0.2 0.3 0.5 2.5
Helsinki 173 0.4 0.1 0.3 0.4 0.6 1.0
NO2 (µg/m3)
Amsterdam 237 42.7 8.5 30.8 42.2 53.9 93.5
Erfurt 177 28.9 6.7 18.5 26.5 36.8 81.7
Helsinki 182 31.1 10.7 22.8 29.7 35.5 67.5
SO2 (µg/m3)
Amsterdam 237 6.7 0.2 3.5 5.5 8.8 32.8
Erfurt 177 5.6 0.5 2.7 3.8 6.0 46.7
Helsinki 180 5.8 0.2 2.8 4.6 7.5 35.0
Temperature (°C)
Amsterdam 237 7.8 –4.0 4.6 7.5 11.6 20.1
Erfurt 177 3.7 –7.8 0.8 4.4 6.7 13.6
Helsinki 182 –1.7 –24.3 –4.6 –0.4 2.2 11.5
Barometric pressure (mbar)
Amsterdam 237 1,014 988 1,008 1,014 1,021 1,041
Erfurt 176 1,016 992 1,008 1,016 1,023 1,040
Helsinki 181 1,012 961 1,001 1,011 1,022 1,040
Relative humidity (%)
Amsterdam 237 86 48 81 87 92 100
Erfurt 177 86 64 82 86 90 99
Helsinki 182 86 51 82 88 92 98
aAmsterdam, 3 November 1998–18 June 1999; Erfurt, 14 October 1998–31 March 1999; Helsinki, 2 November 1998–30 April
1999. bPercentiles.slightly higher in Amsterdam than in Erfurt;
Helsinki had considerably lower number con-
centrations in this size fraction. The mean and
maximum mass concentrations of PM2.5 were
lowest in Helsinki and comparable in Erfurt
and Amsterdam. Because of the longer study
period in Amsterdam, the mean temperature
there varied between –4.0°C and 20.1°C.
Erfurt had a maximum of 13.6°C, and
Helsinki a maximum of 11.5°C, reﬂecting the
colder season. Concentrations of gaseous air
pollutants were highest in Amsterdam; Erfurt
and Helsinki had rather similar concentrations.
Figure 1A–C shows UFP and PM2.5 con-
centrations and temperature during the study
periods. UFP concentrations were not strongly
correlated with ACP and PM2.5, whereas ACP
concentrations were highly correlated with
PM2.5 (Table 3). The correlation between
gaseous and particulate air pollutants was
highest for ACP in all three centers (Table 3).
Blood pressure. Center-specific and
pooled estimates for blood pressure in supine
position in association with UFP, ACP, and
PM2.5 are given in Table 4. Pooled effect esti-
mates suggest a decrease in systolic as well as
diastolic blood pressure with UFP. Effects
were homogeneous for the 5-day average and
showed a decrease in systolic blood pressure
by 0.72 mm Hg [95% confidence interval
(CI), –1.92 to 0.49] and diastolic blood pres-
sure by 0.70 mm Hg (95% CI, –1.38 to
–0.02) in association with an increase of
10,000 UFP per cubic centimeter. However,
results for same-day effects of UFP were het-
erogeneous and showed a decrease in blood
pressure for Erfurt and Helsinki, but a signiﬁ-
cant increase for Amsterdam. ACP is also
associated with a decrease in systolic and dias-
tolic blood pressure. Homogeneous signifi-
cant effects were seen with same-day and with
5-day average pollutant concentrations. PM2.5
was associated with a small decrease in blood
pressure, with significant effect estimates for
diastolic blood pressure on the same day of
exposure, 1-day lag, and the 5-day average
concentrations of PM2.5.
Figure 2 illustrates center-specific and
pooled effect estimates of particulate as well as
gaseous air pollutants on diastolic blood pres-
sure. Estimates are given per increase in pollu-
tant as shown in the legend. In Amsterdam,
effect estimates for UFP and ACP point in the
opposite directions; all the other pollutants do
not seem to have a signiﬁcant effect on dias-
tolic blood pressure. Erfurt shows an immedi-
ate as well as cumulative decrease of diastolic
blood pressure in association with all pollu-
tants, with the highest effects for particles in
the UFP range at lag 0 and in the 5-day aver-
age. In Helsinki, effect estimates scatter around
zero for all pollutants.
Results of the effects of particulate air pol-
lutants on blood pressure in standing position
are shown in Table 5. Pooled effect estimates
are mainly consistent with those seen in supine
position. Signiﬁcant effect estimates for systolic
blood pressure in standing position are higher
than those for supine position. Significant
effects on diastolic blood pressure are mostly
comparable with those observed in supine posi-
tion. Center-speciﬁc estimates show a higher
decrease of systolic blood pressure for UFP and
ACP in Erfurt. Results for Amsterdam are also
comparable in the UFP range, but less so for
ACP and PM2.5. Helsinki does not show any
signiﬁcant associations between particles and
blood pressure in standing position.
Heart rate. Center-specific and pooled
effect estimates of particulate air pollution on
Environmental Medicine | Ibald-Mulli et al.
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Figure 1. Time series of 24-hr mean number concentrations of UFP, PM2.5, and temperature for
(A) Amsterdam, (B) Erfurt, and (C) Helsinki [note that the temperature scale in (C) differs from those in (A)
and (B)].
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April 1999heart rate are shown in Figure 3. Only at lag 2,
a borderline signiﬁcant decrease in heart rate
can be seen in association with fine particles
and UFP looking at pooled effect estimates.
This decrease is mainly driven by Amsterdam,
which shows a signiﬁcant decrease in heart rate
in association with ACP. SO2 had a borderline
signiﬁcant negative effect on heart rate in asso-
ciation with pollutant concentrations on the
day before the clinical visit (1-day lag), with a
pooled effect estimate of –0.40 (95% CI,
–0.82 to 0.01) beats/min for an increase of
5µ g/m3 SO2. CO and NO2 were not associ-
ated significantly with changes in heart rate
(data not shown).
Subgroup analyses. Because of a lack of a
clear effect on heart rate, subgroup analyses
were conducted only for blood pressure.
Figure 4 illustrates the effects of all particle
fractions on systolic and diastolic blood
pressure stratified by myocardial infarction
status. The decrease of systolic blood pressure
seems to be more pronounced in subjects
with prior myocardial infarction in terms of
same-day exposure and the 5-day average
concentration of particles. With regard to
diastolic blood pressure, effects for the same
day of exposure to particles and the 5-day
average exposure were also more signiﬁcant in
subjects with prior myocardial infarction.
However, estimates for 2-day lagged exposure
were heterogeneous between centers. Further
subgroup analyses by intake of blood pressure
active medication or by NYHA criteria did
not disentangle the differences seen for
center-speciﬁc estimates.
Discussion
The results of this multicenter study suggest a
small decrease in diastolic as well as systolic
blood pressure in association with ﬁne parti-
cles and gaseous air pollution in cardiac
patients. This decrease seems to be mostly
driven by patients with prior myocardial
infarction. Further, the results suggest a slight
decrease of heart rate in association with a 
2-day lagged exposure to ambient particle con-
centrations. Particles in the UFP range did not
show homogeneous effects across centers.
However, effects of UFP on blood pressure in
supine as well as in standing position were
Environmental Medicine | Particle effects on blood pressure and heart rate
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Table 3. Center-speciﬁc correlation coefﬁcients of daily concentrations of air pollutants.
ACP PM2.5 NO2 CO SO2
UFP (n/cm3)
Amsterdam 0.16 –0.15 0.49 0.22 0.48
Erfurt 0.67 0.62 0.82 0.72 0.56
Helsinki 0.53 0.14 0.72 0.35 0.49
ACP (n/cm3)
Amsterdam 0.80 0.67 0.60 0.67
Erfurt 0.84 0.82 0.78 0.57
Helsinki 0.80 0.72 0.51 0.49
PM2.5 (µg/m3)
Amsterdam 0.49 0.58 0.48
Erfurt 0.82 0.77 0.69
Helsinki 0.35 0.40 0.44
NO2 (µg/m3)
Amsterdam 0.76 0.72
Erfurt 0.86 0.63
Helsinki 0.32 0.41
CO (mg/m3)
Amsterdam 0.50
Erfurt 0.68
Helsinki 0.19
Table 4. Association between particulate air pollution and blood pressure in supine position adjusted for trend, temperature, barometric pressure, relative humidity,
medication, and day of the week [β (95% CI)].
Amsterdam Erfurt Helsinki Pooled
Systolic blood pressure
UFP (10,000/cm3)
Lag 0 1.87 (–0.33 to 4.07) –0.62 (–1.40 to 0.16) –1.06 (–2.57 to 0.45) –0.47 (–1.16 to 0.22)*
Lag 1 1.69 (–0.66 to 4.04) –0.52 (–1.48 to 0.44) –0.36 (–1.73 to 1.01) –0.25 (–1.00 to 0.50)
Lag 2 0.35 (–1.86 to 2.56) –0.33 (–1.45 to 0.79) –0.52 (–1.85 to 0.81) –0.31 (–1.11 to 0.49)
5-Day average 0.56 (–3.24 to 4.36) –0.84 (–2.43 to 0.75) –0.89 (–3.01 to 1.23) –0.72 (–1.92 to 0.49)
ACP (1,000/cm3)
Lag 0 –0.43 (–1.67 to 0.82) –0.71 (–1.55 to 0.13) –0.88 (–2.61 to 0.85) –0.66 (–1.3 to –0.01)
Lag 1 0.84 (–0.38 to 2.05) –0.59 (–1.55 to 0.36) –0.17 (–1.84 to 1.50) –0.07 (–0.75 to 0.62)
Lag 2 1.12 (–0.02 to 2.26) –1.34 (–2.2 to –0.47) –1.35 (–2.86 to 0.16) –0.51 (–1.85 to 0.83)*
5-Day average 0.37 (–1.47 to 2.20) –1.68 (–3.04 to –0.32) –2.06 (–4.81 to 0.69) –1.11 (–2.12 to –0.09)
PM2.5 (10 µg/m3)
Lag 0 –0.06 (–0.95 to 0.84) –0.36 (–0.83 to 0.11) –0.44 (–2.27 to 1.40) –0.30 (–0.71 to 0.11)
Lag 1 0.18 (–0.74 to 1.10) –0.40 (–0.91 to 0.11) –0.17 (–1.69 to 1.35) –0.25 (–0.68 to 0.18)
Lag 2 0.93 (0.01 to 1.85) –0.68 (–1.20 to –0.17) –1.14 (–2.51 to 0.23) –0.26 (–1.22 to 0.70)*
5-day average 0.49 (–0.74 to 1.72) –0.68 (–1.44 to 0.09) –0.59 (–3.08 to 1.90) –0.36 (–0.99 to 0.27)
Diastolic blood pressure
UFP (10,000/cm3)
Lag 0 1.26 (–0.01 to 2.53) –0.61 (–1.06 to –0.16) –0.28 (–1.10 to 0.54) –0.12 (–0.84 to 0.60)*
Lag 1 1.52 (0.17 to 2.87) –0.61 (–1.16 to –0.06) –0.05 (–0.79 to 0.69) 0.06 (–0.77 to 0.89)*
Lag 2 –0.19 (–1.50 to 1.12) –0.35 (–0.98 to 0.28) –0.36 (–1.09 to 0.37) –0.34 (–0.78 to 0.11)
5-Day average 0.65 (–1.58 to 2.88) –1.17 (–2.07 to –0.27) –0.28 (–1.46 to 0.90) –0.70 (–1.38 to –0.02)
ACP (1,000/cm3)
Lag 0 –0.50 (–1.23 to 0.23) –0.57 (–1.05 to –0.09) –0.08 (–1.04 to 0.88) –0.48 (–0.85 to –0.11)
Lag 1 0.09 (–0.62 to 0.79) –0.57 (–1.11 to –0.03) –0.14 (–1.07 to 0.79) –0.29 (–0.68 to 0.10)
Lag 2 0.08 (–0.61 to 0.76) –0.72 (–1.21 to –0.23) –0.52 (–1.35 to 0.32) –0.46 (–0.82 to –0.10)
5-Day average –0.34 (–1.43 to 0.75) –1.24 (–2.01 to –0.47) –1.00 (–2.52 to 0.51) –0.95 (–1.53 to –0.37)
PM2.5 (10 µg/m3)
Lag 0 –0.29 (–0.34 to 0.22) –0.29 (–0.56 to –0.02) 0.22 (–0.79 to 1.23) –0.27 (–0.5 to –0.03)
Lag 1 –0.36 (–0.89 to 0.17) –0.31 (–0.61 to –0.02) –0.08 (–0.92 to 0.75) –0.30 (–0.55 to –0.05)
Lag 2 0.10 (–0.44 to 0.64) –0.27 (–0.56 to 0.03) –0.38 (–1.13 to 0.38) –0.20 (–0.45 to 0.05)
5-Day average –0.27 (–0.98 to 0.44) –0.42 (–0.86 to 0.02) –0.52 (–1.88 to 0.85) –0.39 (–0.75 to –0.03)
*p-Value for test of heterogeneity < 0.1.signiﬁcant for the Erfurt panel and consistent
across all exposure variables.
Blood pressure and heart rate are physio-
logic parameters that can be used to assess
changes in autonomic control of the heart
and vascular tone (Grassi et al. 1998; Noll
et al. 1998). Evidence has been provided that
the activation of the sympathetic nervous sys-
tem plays an important role in the regulation
of blood pressure (Grassi 1998). Previous and
recent study results showed increases in sys-
tolic as well as diastolic blood pressure with
elevated concentrations of ambient particle
pollution (Ibald-Mulli et al. 2001; Linn et al.
1999; Zanobetti et al. 2002). An increase of
sympathetic tone in association with particu-
late air pollution and/or the modulation of
basal systemic vascular tone due to increased
concentrations of endothelin associated with
particulate air pollution were suggested as
potential mechanisms for this increase in
blood pressure (Ibald-Mulli et al. 2001). The
findings on the association of particulate air
pollution on blood pressure also complement
results on the alteration of heart rate variabil-
ity and arrhythmia seen in association with
exposure to higher particle concentrations in
ambient air (Gold et al. 2000; Peters et al.
2000a, 2000b; Pope et al. 1999a). However,
in a recent chamber exposure study conducted
by a group from the University of Southern
California (Gong et al. 2002), a decrease in
systolic blood pressure after exposure to con-
centrated air particles relative to ﬁltered air in
asthmatics was reported.
There is some evidence that short-term
variations in particulate air pollution are associ-
ated with an increase in heart rate (Peters et al.
1999; Pope et al. 1999b). However, Gold et al.
(2000) observed a decrease in heart rate in
association with PM2.5 in a panel of elderly.
Including the ﬁndings of the presented study,
overall evidence on the effects of particulate air
pollution on blood pressure and heart rate
seems challenging. A decrease in blood pressure
in association with fine particles cannot be
explained by the underlying mechanisms that
were suggested in previous studies.
Although the effects seen in this analysis
are very small, they seem to be more pro-
nounced after postural change from supine to
standing position with respect to systolic
blood pressure, which might indicate auto-
nomic imbalance in association with particle
concentrations. Further, the decrease in dias-
tolic blood pressure was higher in individuals
with prior myocardial infarction, which might
indicate that they are more likely to respond
to particle exposure. One possible mechanism
for the decrease in blood pressure could be a
shift in sympathovagal balance due to an
increase in vagal tone (Laitinen et al. 1999).
Environmental Medicine | Ibald-Mulli et al.
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Figure 2. Center-specific and pooled effects of
particulate and gaseous air pollutants on diastolic
blood pressure in supine position. (A) Amsterdam.
(B) Erfurt. (C) Helsinki. (D) Pooled (the effect scale
differs for Amsterdam). Error bars indicate 95% CIs.
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Table 5. Association between particulate air pollution and blood pressure in standing position adjusted for trend, temperature, barometric pressure, relative
humidity, medication, and day of the week [β (95% CI)].
Amsterdam Erfurt Helsinki Pooled
Systolic blood pressure
UFP (10,000/cm3)
Lag 0 2.38 (–0.46 to 5.22) –0.88 (–2.00 to 0.24) –0.18 (–2.36 to 2.00) –0.39 (–1.33 to 0.54)
Lag 1 3.33 (0.21 to 6.45) –1.43 (–2.8 to –0.06) –0.50 (–2.48 to 1.48) –0.04 (–1.94 to 1.86)*
Lag 2 0.81 (–2.11 to 3.73) –1.86 (–3.43 to –0.29) –0.87 (–2.79 to 1.05) –1.13 (–2.25 to –0.01)
5-Day average 2.68 (–2.36 to 7.72) –2.75 (–4.98 to –0.52) –0.86 (–3.92 to 2.20) –1.55 (–3.25 to 0.15)
ACP (1,000/cm3)
Lag 0 –0.60 (–2.23 to 1.03) –0.62 (–1.81 to 0.57) 0.83 (–1.67 to 3.34) –0.42 (–1.32 to 0.47)
Lag 1 1.01 (–0.57 to 2.58) –1.02 (–2.37 to 0.34) 0.38 (–2.03 to 2.80) –0.08 (–1.02 to 0.87)
Lag 2 0.29 (–1.18 to 1.76) –2.11 (–3.34 to –0.89) –1.07 (–3.23 to 1.09) –1.02 (–2.29 to 0.27)*
5-Day average –0.07 (–2.42 to 2.28) –1.84 (–3.76 to 0.08) –2.19 (–6.13 to 1.75) –1.27 (–2.66 to 0.13)
PM2.5 (10 µg/m3)
Lag 0 –0.44 (–1.6 to 0.72) –0.59 (–1.24 to 0.06) 1.17 (–1.46 to 3.80) –0.48 (–1.03 to 0.07)
Lag 1 –0.61 (–1.8 to 0.59) –0.70 (–1.42 to 0.03) 0.01 (–2.17 to 2.19) –0.62 (–1.21 to –0.03)
Lag 2 0.32 (–0.88 to 1.51) –0.65 (–1.37 to 0.07) –0.63 (–2.60 to 1.34) –0.41 (–1.00 to 0.17)
5-Day average –0.55 (–2.15 to 1.04) –0.68 (–1.74 to 0.39) –1.96 (–5.51 to 1.60) –0.72 (–1.57 to 0.14)
Diastolic blood pressure
UFP (10,000/cm3)
Lag 0 1.69 (0.18 to 3.20) –0.52 (–1.13 to 0.09) –0.72 (–1.94 to 0.50) 0.03 (–1.05 to 0.21)*
Lag 1 1.29 (–0.42 to 3.00) –0.51 (–1.25 to 0.23) 0.32 (–0.80 to 1.44) –0.07 (–0.66 to 0.51)
Lag 2 0.77 (–0.84 to 2.38) –0.67 (–1.53 to 0.19) –0.35 (–1.43 to 0.73) –0.35 (–0.97 to 0.27)
5-Day average 2.42 (–0.27 to 5.11) –1.12 (–2.34 to 0.10) –0.28 (–2.00 to 1.44) –0.21 (–1.47 to 1.05)*
ACP (1,000/cm3)
Lag 0 0.28 (–0.62 to 1.18) –0.63 (–1.28 to 0.02) –1.09 (–2.48 to 0.30) –0.41 (–0.91 to 0.08)
Lag 1 –0.16 (–1.04 to 0.71) –0.64 (–1.38 to 0.10) –0.05 (–1.39 to 1.29) –0.38 (–0.9 to 0.14)
Lag 2 –0.20 (–1.02 to 0.62) –0.93 (–1.6 to –0.26) –0.63 (–1.83 to 0.57) –0.63 (–1.11 to –0.16)
5-Day average –0.38 (–1.68 to 0.92) –0.86 (–1.91 to 0.19) –1.31 (–3.49 to 0.88) –0.75 (–1.51 to 0.01)
PM2.5 (10 µg/m3)
Lag 0 –0.14 (–0.76 to 0.48) –0.51 (–0.86 to –0.15) –0.81 (–2.29 to 0.67) –0.44 (–0.74 to –0.14)
Lag 1 –0.41 (–1.05 to 0.22) –0.35 (–0.75 to 0.04) –0.44 (–1.66 to 0.79) –0.37 (–0.70 to –0.05)
Lag 2 –0.24 (–0.88 to 0.40) –0.15 (–0.55 to 0.25) –0.18 (–1.29 to 0.93) –0.18 (–0.50 to 0.15)
5-Day average –0.58 (–1.43 to 0.27) –0.27 (–0.85 to 0.32) –0.46 (–2.47 to 1.54) –0.37 (–0.84 to 0.10)
*p-Value for test of heterogeneity < 0.1.The results of the heart rate variability analyses
within the same study (Timonen KL et al.,
unpublished data) found a slight increase in
high-frequency power, a frequency domain
parameter of heart rate variability mainly
inﬂuenced by vagal tone. Further, a decrease
in the ratio between low- and high-frequency
power reﬂecting a shift in sympathovagal bal-
ance toward vagal tone was observed. These
findings agree with the observed decrease of
blood pressure and heart rate.
The ULTRA study used a time-series
approach comparable with other panel stud-
ies. All procedures were standardized, and
panels were selected based on the same inclu-
sion and exclusion criteria in all three centers.
The results are suggestive of particle effects
and are homogeneous for ACP and PM2.5;
only for particles in the UFP range do they
not show consistent patterns between centers.
Looking at effect estimates within each center
(Figure 2), mainly the Erfurt panel shows a
consistent decrease in blood pressure across all
exposure variables. Previous studies in Erfurt
have shown particle effects on lung function
and mortality with a similar relation between
the effects of UFP and ACP (Ibald-Mulli
et al. 2002; Klot et al. 2002; Wichmann et al.
2000).
To discuss the differences seen in the
effect estimates between centers and differ-
ences compared with other study results, two
major questions need to be addressed. First,
how can differences or measurement error in
the assessment of exposure affect the results?
Time-series studies of acute air pollution
effects are subject to limitations because of
available measurements of pollution levels. It
has been shown that the particle-measuring
devices in all three centers are comparable
(Khlystov et al. 2001; Ruuskanen et al. 2001;
Tuch et al. 2000). However, factors such as
wind direction, climatic conditions, long-
range transport, and distances from sources
affect exposure patterns between pollutants
(Croxford et al. 1996; Cyrys et al. 1998;
Pakkanen et al. 2001; Vignati et al. 1996).
Table 3 shows the variation in correlation pat-
terns within the different particle size fractions
between the three centers. Figure 2 shows that
the effect estimates for UFP and PM2.5 in asso-
ciation with diastolic blood pressure point in
opposite directions for Amsterdam, where the
ratio between ACP and UFP is very different
compared with Erfurt and Helsinki (Tables 2
and 3). Furthermore, although considerable
effort was made to measure new physical para-
meters of the ambient urban aerosol beyond
the classical mass-derived data, the effect of the
chemical composition of the aerosols was not
assessed in the present analyses. It is very likely
that the chemical composition of the aerosol
differed between the three cities, which may
have affected the different response patterns
indicated in Figure 2.
Second, how different is the panel com-
position between the three centers with
respect to coronary heart disease status and
medication use, and how do they compare
with other study populations? Medication use
differs significantly from one center to the
others, and the Erfurt panel seems to have the
highest medication intake, particularly with
respect to blood pressure active medication
(Table 1). As opposed to a population not
taking blood pressure medication, as looked
at in other studies (Ibald-Mulli et al. 2001;
Linn et al. 1999), effects of medication might
blunt or modify the autonomic response to
air pollution exposure. This might partially
explain the differences in ﬁndings by center.
It has been shown that the effects of cardio-
vascular drugs on the sympathetic nervous
system may be of great importance; depend-
ing on their pharmacologic profile, they can
either activate or inhibit sympathetic activity
(Noll et al. 1998). Therefore, the suggested
mechanisms, such as an increase in sympa-
thetic tone as a response to elevated particle
concentrations, might not apply in patients
with a high intake of cardiac medication.
Although it has been postulated that
patients with cardiovascular disease are more
susceptible to air pollution, most of the evi-
dence with respect to heart rate, blood pres-
sure, and heart rate variability has been found
in populations without cardiovascular disease.
Based on our results, the question arises how
appropriate or powerful currently used para-
meters such as heart rate variability, heart rate,
and blood pressure are assessing effects of air
pollution in cardiac patients. As suggested by
Zareba et al. (2001), a comprehensive analysis
should be conducted of ECG parameters
Environmental Medicine | Particle effects on blood pressure and heart rate
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Figure 3. Center-specific and pooled effects of
particulate and gaseous air pollutants on heart
rate in supine position. (A) Amsterdam. (B) Erfurt.
(C) Helsinki. (D) Pooled. Error bars indicate 95% CIs.
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Figure 4. Effects of ambient particles on systolic and diastolic blood pressure in supine position of cardiac
patients with and without myocardial infarction (MI). Error bars indicate 95% CIs.
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▼describing not only the autonomic nervous
system but also parameters reflecting myo-
cardial repolarization such as QT-interval
duration and T-wave morphology and parame-
ters indicating cardiac arrhythmias and
ischemia such as QT-interval synamics and
ST-segment depressions. A preliminary analy-
sis of arrhythmia within the same study
showed an increase in ventricular ectopic beats
in association with particulate air pollution in
all three centers (Peters et al 2001b).
Pekkanen et al. (2002) did observe an
association of particulate air pollution on 
ST-segment depression in the Finnish panel,
suggesting that the particle effect is partly
mediated through increased susceptibility to
myocardial ischemia.
With respect to the effects on blood pres-
sure and heart rate, it would not be appropri-
ate to draw any conclusions regarding the
clinical relevance of these findings because
there is not enough epidemiologic evidence.
However, it has been shown in animal studies
that afferent nervous receptors in the lower
respiratory tract are sensitive to irritants and
pollutants and by reflex cause pronounced
bradycardia and hypotension (Widdicombe
and Lee 2002). Stone and Godleski (1999)
hypothesized that inhaled environmental par-
ticles may promote a systemic sympathetic
stress response as well as stimulate irritant
receptors in the lung parenchyma and respira-
tory airways, which can lead to increased
vagal responses of the heart, possibly causing
bradyarrhythmias in appropriate settings.
Therefore, the imbalance of the autonomic
nervous system in either direction could lead
to a decrease or an increase in blood pressure
and may result in adverse cardiac events.
Overall, there is convincing evidence that
particulate air pollution is associated with
cardiovascular health (Gold et al. 2000; Liao
et al. 1999; Pekkanen et al. 2000, 2002;
Peters et al. 1997a, 2000a, 2001a; Pope et al.
1999a). More studies in patients with cardio-
vascular disease need to be conducted to
establish further evidence on how particles
affect the control of blood pressure and heart
rate in a diseased population and how these
effects contribute to adverse health outcomes.
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